The Food and Drug Administration (FDA) has released new guidance aimed at reducing the risk of disease transmission caused by sepsis in human cell and tissue products. This guidance is designed to help organizations that make donor eligibility decisions by recommending practices to lower infection risks. The FDA issued this guidance immediately due to urgent health concerns, updating previous recommendations from 2007. The guidance reflects the FDA's current viewpoints but does not impose any legal obligations.
Simple Explanation
The FDA made a guide to help stop the spread of germs that can make people sick when they use special parts from human bodies, like cells and tissues. They want to make sure these parts are safe, especially because some germs can cause a serious illness called sepsis.